Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul J. Hastings currently holds 31,000 shares of Pacira Pharmaceuticals, Inc. (PCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul J. Hastings has been a net seller of PCRX stock. They have purchased $25.0K and sold $5.1M worth of shares.
Paul J. Hastings's most recent insider trade was on Jun 16, 2026, when they sold 31,000 shares at $0.00 per share.
Paul J. Hastings serves as Executive at Pacira Pharmaceuticals, Inc. (PCRX). They have executed 101 insider transactions totaling $5.2M over their tenure at the company.
Paul J. Hastings holds the position of Executive at Pacira Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Paul J. Hastings has shown a selling trading pattern, with $25.0K in total purchases and $5.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul J. Hastings was on Mar 4, 2024, when they sold $1.8M worth of NKTX shares. This transaction involved 137,642 shares at $13.33 per share.
Paul J. Hastings currently owns 31,000 shares of Pacira Pharmaceuticals, Inc. (PCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul J. Hastings's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul J. Hastings has 101 Form 4 filings on record as an insider at Pacira Pharmaceuticals, Inc..
Set alerts for Paul J. Hastings and 40,000+ other insiders.